Print Version
Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection
Publication Date:
2011
Country of Origin:
United States
Format:
Information Sheet
Language:
English
Abstract
This information sheet discusses interferon-gamma release assays (IGRAs), which are whole-blood tests used in diagnosing both latent TB infection and TB disease. It notes that two IGRAs have been approved by the US Food and Drug Administration (FDA) and are commercially available in the United States. The information sheet explains how the IGRAs work; the advantages, disadvantages, and limitations of IGRAs; steps in administering these tests; interpretation; recommendations on when to use them; and whether IGRAs can be given to persons receiving vaccinations.
Publisher:
Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention
Audience(s):
Health Professionals
Topic:
Diagnosis- Screening
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.